EvaluateMedTech World Preview 2018, Outlook to 2024

Worldwide medtech sales forecast to reach $595bn by 2024

The new edition of the EvaluateMedTech World Preview is now available. The report shows that the medical device and diagnostics industry will reach $595 billion in sales by 2024 (CAGR of 5.6%). Medtronic is forecast to continue to be the leading medtech company in 2024 with sales of $39 billion.

The EvaluateMedTech World Preview 2018 highlights trends in medtech and includes consensus sales forecasts by device area to 2024, the top 20 companies in 2024, R&D spend current and future and FDA approvals.

Key Highlights

  • Neurology set to be the fastest-growing device area, with a CAGR of 9.1% between 2017 and 2024

  • In vitro diagnostics remains the number one device area in 2024 with sales of $79.6bn; Roche forecast to hold 18% of the market

  • Medtronic will remain the top group in cardiology in 2024 with sales of $14.2bn, a 20% market share

  • Diagnostic imaging sales are forecast to reach $51bn in 2024; Siemens Healthineers, General Electric and Philips continue to dominate the market

  • Essilor will continue to dominate the ophthalmics market in 2024, with forecast sales of $11.6bn